methylphenazonium methosulfate has been researched along with norfloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillette, WK; Martin, RG; Rosner, JL | 1 |
| Barras, F; Bouveret, E; Duverger, Y; Gerstel, A; Py, B; Zamarreño Beas, J | 1 |
2 other study(ies) available for methylphenazonium methosulfate and norfloxacin
| Article | Year |
|---|---|
Promoter discrimination by the related transcriptional activators MarA and SoxS: differential regulation by differential binding.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Binding Sites; DNA-Binding Proteins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Isopropyl Thiogalactoside; Methylphenazonium Methosulfate; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Norfloxacin; Promoter Regions, Genetic; Substrate Specificity; Superoxides; Trans-Activators; Transcription Factors; Vitamin K | 2000 |
Oxidative stress antagonizes fluoroquinolone drug sensitivity via the SoxR-SUF Fe-S cluster homeostatic axis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Drug Antagonism; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Iron-Sulfur Proteins; Methylphenazonium Methosulfate; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Transcription Factors | 2020 |